Fleming RV, Walsh TJ, Anaissie EJ. Emerging and less common fungal pathogens. Infect Dis Clin North Am. 2002;16: 915-933.
2.
Fishman JA. Overview: fungal infections in the transplant patient. Transpl Infect Dis.2002;4(S3):3-11.
3.
Walsh TJ, Lee JW. Prevention of invasive fungal infections in patients with neoplastic disease. Clin Infect Dis.1993;17(S2): S468-S480.
4.
Subbash HS, Christopher DJ, Roy A, Cherian AM. Pulmonary nocardiosis in human immunodeficiency virus infection: a tuberculosis mimic. J Postgrad Med.2001;47:30-32.
5.
Sumer Y, Yilmaz B, Emre B, Ugur C.Abdominal mass secondary to actinomyces infection: an unusual presentation and its treatment. J Postgrad Med.2004;50:115-117.
6.
Lamb SR, Stables GI, Merchant W.Disseminated cutaneous infection with Mycobacterium chelonae in a patient with steroid-dependent rheumatoid arthritis. Clin Exp Dermatol. 2004;29: 254-257.
7.
Eberhardt C, Kuerschner L, Weiss DS. Probing the catalytic activity of cell division-specific transpeptidase in vivo with beta-lactams. J Bacteriol. 2003;185:3726-3734.
8.
Nguyen-Disteche M, Fraipont C, Buddelmeijer N, Nanninga N.The structure and function of Escherichia coli penicillinbinding protein 3. Cell Mol Life Sci.1998;54:309-316.
9.
Woodworth GF, McGirt MJ, Williams MA, Rigamonti D. The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis. Surg Neurol. 2005; 63:529-531.
